Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
The University of Texas Health Science Center at San Antonio
The aims of this study are to: * Assess the efficacy of adding pegylated IFN-α2b to denileukin diftitox to treat selected advanced-stage epithelial ovarian cancers * Test the immune-modulating effects of adding pegylated IFN-α2b to denileukin diftitox in ovarian cancer patients and relate them to clinical efficacy * Identify any toxicity associated with pegylated IFN-α2b plus denileukin diftitox treatment in these patients * Identify practical means to dose the immunomodulating agents denileukin diftitox and pegylated IFN-α2b based on immunopharmacodynamic metrics
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted